New insights into rare liver cancer as clinical trial for treatment begins
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...
Announcing a new article publication for BIO Integration journal. Primary hepatic lymphoepithelioma-like carcinoma (LELC) is a malignant tumor with a ...
A new research paper was published in Genes & Cancer on February 5, 2023, entitled, "Mechanistically based blood proteomic markers ...
A recent International Journal of Obesity study explores the role of brain and muscle aryl hydrocarbon receptor nuclear translocator-like1 (BMAL1) in the ...
In a recent review published in the Nutrients Journal, researchers reviewed existing data on dietary patterns, foods, and nutrients to ...
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality ...
Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of ...
The most common type of liver cancer, hepatocellular carcinoma (HCC), is already the third leading cause of cancer-related deaths globally-;and ...
Dec 27 2022 UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net